ClinicalTrials.gg
Not yet recruitingNCT06962618THRIVE-CPUpdated May 8, 2025

Home-Based Training With Feedback to Improve Outcomes in Adolescents and Young Adults With Cerebral Palsy..

An interventional study of Music Motion Group and Control in Cerebral Palsy, sponsored by University of Copenhagen. Not yet recruiting at 1 site in Denmark. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2025-05-08.

Sponsored by University of Copenhagen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
15 Years to 25 Years
Sex
All
01

Study summary

This clinical trial aims to determine whether extrinsic feedback through music enhances the effects of home-based motor training for adolescents and young adults with cerebral palsy (CP) and whether feedback improves adherence to the training program.

The main questions it aims to answer are:

  • Does extrinsic feedback improve real-world movement more than home training alone?
  • Do participants receiving extrinsic feedback adhere more closely to their training program?

To determine its effectiveness, the investigators will compare home-based training with and without real-time music feedback.

Participants will:

  • Engage in a home-based motor training program for 12 weeks, tailored to their individual needs and goals.
  • Receive real-time music feedback during training or no feedback (control group).
  • Attend weekly virtual coaching sessions to discuss short-term goals and training progress.
  • Undergo movement assessments before training, at 12 weeks (T2) and 24 weeks (T3).
  • Wear movement sensors for 72 hours at T2 and T3 to track real-world movement behavior.
02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • cerebral palsy
  • Home-based training
  • Extrinsic feedback
  • Movement behavior
  • Motor learning
03

In context

Cerebral Palsy

1,891 studies on the registry are indexed under Cerebral Palsy; 439 are open to participants now.

This study's planned enrollment of 70 is above the median of 34 across 1,396 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

University of Copenhagen is the lead sponsor of 465 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of cerebral palsy
  • Sensorimotor deficits in at least one limb
  • Demonstrated motivation to develop or regain motor skills, indicated by the expression of specific goals
  • Ability to follow instructions independently or with caregiver support
  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of dyskinetic cerebral palsy
  • Presence of significant health risks that could interfere with participation
  • Surgery or first Botox injection within one month before the trial or during the trial period
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Music Motion Group

    Behavioral: Music Motion Group

  • Active comparator
    Control

    Behavioral: Control

Interventions

  • BehavioralMusic Motion Group

    Participants will engage in personalized, home-based motor training programs tailored to their individual goals. Each will wear a wireless Inertial Measurement Unit (IMU) on the targeted body part, which transmits movement data via Bluetooth to a tablet app. The training emphasizes task specificity and intensity, with five virtual check-ins to review progress and adjust training parameters. The intervention studied is extrinsic feedback; the app analyzes movement data and provides feedback through music. Before each training session, the app guides participants to set personalized intensity thresholds based on current capacity. When participants meet the intensity threshold, musical elements (e.g., drumbeats, vocals) play. If they fall short, elements drop out, providing knowledge of erroneous performance.

  • BehavioralControl

    Participants will follow personalized, home-based motor training programs designed like the Music motion group. They will wear a wireless Inertial Measurement Unit (IMU) on the targeted body part, transmitting movement data via Bluetooth to a tablet app. However, unlike the Music Motion Feedback group, participants in the Control group will not receive any extrinsic feedback during their training.

06

What researchers measure

Primary outcomes

  1. Percentage change in daytime movement of the trained extremity (right or left arm or leg) as measured by 3-axis accelerometer and gyroscope data analyzed via deep-learning neural network

    Movement data will be collected using seven Inertial Measurement Units (IMUs) worn continuously for 72 hours at three time points: baseline, 12 weeks (end of intervention), and 24 weeks (follow-up). IMUs will be attached to the sternum, wrists, thighs, and lower legs using adhesive patches and will capture 3-axis accelerometer and gyroscope data. A validated custom neural network (Novosel et al. 2023) will convert signals into images and analyze them using convolutional layers to extract features related to movement behaviors. The primary metric will be the percentage change (minutes a day) in real-world daytime movement of the trained limb, computed relative to baseline. This outcome reflects changes in functional mobility resulting from the motor training intervention.

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

Secondary outcomes

  1. Number of daily logins to the tablet app

    Attendance will be measured as the number of times participants log into the tablet app during the intervention. Unit of Measure: Number of logins

    Time frame: The app stores the data during the intervention period and will be collected at 12 weeks (end of intervention period)

  2. Daily session duration recorded in the tablet app

    Adherence will be assessed by the average length of each daily training session. This outcome reflects how long participants remain engaged with the motor training program once they log in. Unit of Measure: Minutes

    Time frame: The app stores the data during the intervention period and will be collectedThe app stores the data during the intervention period and will be collected at 12 weeks (end of intervention period)

  3. Time spent moving the targeted extremity during training recorded in the tablet app

    This measure reflects adherence by quantifying the active movement time of the trained extremity during each training session. Unit of Measure: Minutes

    Time frame: The app stores the data during the intervention period and will be collected The app stores the data during the intervention period and will be collected at 12 weeks (end of intervention period)

  4. Time spent within target movement intensity threshold recorded in the tablet app

    For participants in the Music Motion Feedback group, adherence will also be evaluated by measuring the time spent at or above a predefined movement intensity threshold. Unit of Measure: Minutes

    Time frame: The app stores the data during the intervention period and will be collected The app stores the data during the intervention period and will be collected at 12 weeks (end of intervention period)

  5. Action Research Arm Test (ARAT) total score - (Upper Extremity)

    In participants engaged in upper extremity training, the ARAT will be used to evaluate upper extremity functional capacity. It consists of 19 items assessing grasp, grip, pinch, and gross movement. Scores range from 0 to 57, with higher scores indicating better arm function. Time Frame: Baseline, 12 weeks (end of intervention), and 24 weeks (follow-up) Unit of Measure: ARAT total score (0-57)

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  6. Maximum isometric arm strength - (Upper Extremity)

    Participants engaged in upper extremity training will have the isometric strength of the targeted upper extremity measured using a handheld dynamometer. They will perform maximum voluntary contractions against resistance, and the peak force will be recorded. Unit of Measure: Kilograms of force (kgf)

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  7. Maximum grip strength - (Upper Extremity)

    Participants who are engaged in upper extremity training will have their grip strength of the targeted upper limb measured using a hand dynamometer. The highest of three attempts will be recorded. Unit of Measure: Kilograms of force (kgf)

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  8. Gross Motor Function Measure-66 (GMFM-66) total score - (Lower Extremity)

    In participants who are engaged in lower extremity training the GMFM-66 will be used to assess gross motor function. It evaluates activities such as standing, walking, and running. Scores range from 0 to 100, with higher scores indicating better function. Unit of Measure: GMFM-66 total score (0-100)

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  9. Maximum isometric leg strength - (Lower Extremity)

    The isometric strength of the trained leg will be assessed using a handheld dynamometer. Participants will perform maximum voluntary contractions, and peak force will be recorded. Unit of Measure: Kilograms of force (kgf)

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  10. Distance walked during the Six-Minute Walk Test (6MWT) - (Lower Extremity)

    The 6MWT will be used to evaluate walking endurance and aerobic capacity. Participants engaged in lower extremity training will walk as far as possible in six minutes along a flat, indoor course. Time Frame: Baseline, 12 weeks, and 24 weeks Unit of Measure: Meters walked

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

Other outcomes

  1. The Canadian Occupational Performance Measure (Self-Rated Performance)

    During a semi-structured interview, participants identify an activity they want, need, or are expected to perform and set one long-term goal. They then rate their performance of that activity on a 0-10 scale, where 0 = not able to perform the activity at all and 10 = able to perform it extremely well. Unit of Measure: Performance score (0-10 scale)

    Time frame: Before baseline (at the motor training program design), at 12 weeks (end of intervention), and at 24 weeks (long-term follow-up)

  2. The Canadian Occupational Performance Measure (Self-Rated Satisfaction)

    In the same semi-structured interview, participants rate their satisfaction with their performance of the selected activity on a 0-10 scale, where 0 = not satisfied at all and 10 = extremely satisfied. Unit of Measure: Satisfaction score (0-10 scale)

    Time frame: Before baseline (at the motor training program design), at 12 weeks (end of intervention), and at 24 weeks (long-term follow-up)

  3. Change in time spent walking per day (as measured by IMUs)

    Time spent walking will be measured using 3-axis accelerometer and gyroscope data collected from seven IMUs worn continuously for 72 hours. Data will be analyzed using a validated deep-learning neural network (Novosel et al., 2023) to classify walking behavior. Unit of Measure: Minutes per day

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  4. Change in time spent standing per day (as measured by IMUs)

    Standing time will be extracted from IMU data collected during 72 hours of wear. Signals will be analyzed via a validated deep-learning neural network (Novosel et al., 2023) Time Frame: Baseline, 12 weeks, and 24 weeks Unit of Measure: Minutes per day

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  5. Change in time spent sitting per day (as measured by IMUs)

    Sitting time will be recorded using IMUs worn on the sternum, wrists, thighs, and lower legs after 72 hours of wear and analysed with a validated deep-learning neural network (Novosel et al., 2023) Unit of Measure: Minutes per day

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  6. Change in time spent lying down per day (as measured by IMUs)

    Time spent lying will be measured using 3-axis accelerometer and gyroscope data collected from seven IMUs worn continuously for 72 hours. Data will be analyzed using a validated deep-learning neural network (Novosel et al., 2023) to classify walking behavior. Unit of Measure: Minutes per day

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  7. Change in number of posture transitions per day (as measured by IMUs)

    Posture transitions (e.g., sit-to-stand) will be identified from 72-hour IMU data using a validated deep-learning neural network (Novosel et al., 2023) Unit of Measure: Number of transitions per day

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  8. Change in relative extremity usage ratio

    The movement ratio between the trained and non-trained extremity will be calculated from IMU signals using using a validated deep-learning neural network (Novosel et al., 2023) Unit of Measure: Ratio (trained / non-trained limb)

    Time frame: Baseline, at 12 weeks (end of intervention period), and at 24 weeks (long term follow up)

  9. Adverse events

    Adverse events include both serious (e.g. death, hospitalization) and non-serious adverse events (e.g. pain, fatigue). Unit of Measure: Number of events

    Time frame: Through week 12 (baseline to end of intervention)

07

Study locations

1 site
  • CP Youth Clinic, Copenhagen University Hospital - Rigshospitalet
    Copenhagen, Denmark
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Dec 2028, 36 months later.

Of 882 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 36 months is above that.

Counting every sponsor, half of 900 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2025
First posted
May 8, 2025
StartEst.
Dec 1, 2025
Primary completionEst.
Dec 1, 2028
CompletionEst.
Feb 1, 2029
Last update
May 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06962618
Responsible party
Ivana Bardino Novosel (Principal Investigator, University of Copenhagen) — Principal investigator
First posted
May 8, 2025
Start date
Dec 1, 2025 (estimated)
Primary completion
Dec 1, 2028 (estimated)
Completion
Feb 1, 2029 (estimated)
Last update
May 8, 2025

Study contacts

Ivana B Novosel, PhD student
Contact
ivana.novosel@sund.ku.dk
27328961 ext. +45
Jakob Lorentzen, Professor
Contact
j.lorentzen@sund.ku.dk
+4531521131
Jakob Lorentzen, Professor
study director · University of Copenhagen and University Hospital Copenhagen, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion